Cronos Group Inc. CRON
CRON Rating
CRON Rating Factors
CRON Company Overview
Cronos Group Inc. is a cannabinoid company focused on the research, production, marketing, and distribution of cannabis and hemp-derived products. The company operates within the global cannabis, consumer packaged goods, and biotechnology-oriented cannabinoid sectors. Cronos develops products for both adult-use recreational and medical cannabis markets, with operations spanning cultivation, manufacturing, branded consumer products, and cannabinoid research. Its primary revenue drivers include cannabis flower, pre-rolls, vapes, edibles, extracts, and cannabinoid ingredient sales under multiple consumer brands.
The company serves adult-use consumers, medical cannabis patients, and cannabinoid ingredient customers across several international markets. Cronos is positioned as a science-driven cannabis operator with a focus on product innovation, intellectual property development, and strategic partnerships. A major differentiator has been its long-standing strategic investment relationship with Altria Group, which acquired a significant equity stake in 2019 and provided capital for expansion and product development initiatives. Cronos traces its origins to Peace Naturals Project Inc., one of Canada’s early licensed medical cannabis producers, before rebranding as Cronos Group and expanding internationally following cannabis legalization developments in Canada and other jurisdictions.
CRON Income Statement
CRON Balance Sheet
CRON Price History
CRON Valuation
CRON Dividends and Shares
CRON Corporate Info
Stayner, ON L0M 1S0